Fig. 2From: Intravoxel incoherent motion MRI as a biomarker of sorafenib treatment for advanced hepatocellular carcinoma: a pilot studyTrue diffusion coefficients (DCs) of the responders and non-responders at baseline, and after 1, 2, and 4 weeks of sorafenib treatment. DC values of the responder group were significantly higher than those of the non-responder group at baselineBack to article page